HRT and bone health: symptoms, screening and fracture prevention

Bone loss can be quiet

Osteoporosis often develops without obvious symptoms until a fracture occurs. The absence of pain, fatigue or menopause symptoms does not establish normal bone density. Similarly, feeling more comfortable after treating hot flashes does not measure how strong your bones are.

Tell the clinician about previous fractures, a family history of hip fracture or osteoporosis, falls, and medicines or conditions that may affect bone. Bring an actual list of medications rather than trying to decide yourself which ones are relevant. Our HRT appointment guide can help organize those details.

Know when screening is worth discussing

The US Preventive Services Task Force recommends osteoporosis screening for women aged 65 or older. For postmenopausal women younger than 65, it recommends first assessing risk factors and using a clinical risk tool when appropriate to decide who is at increased risk and should be screened.

The recommendation applies to screening people without known osteoporosis or a history of fragility fracture; some conditions or medicines require a different clinical pathway. A prior fracture or a specialist-managed condition should therefore be discussed directly, rather than waiting for a screening birthday. Ask how the recommendation applies to your own history.

A blood panel is not a bone-density scan

A DXA scan measures bone mineral density, commonly at the hip and spine. A hormone blood test answers different questions and cannot substitute for that measurement. An online program advertising extensive laboratory testing should explain whether it also assesses fracture risk and arranges imaging when indicated.

Our at-home testing shortlist makes the collection options clear without treating them as a complete bone-health assessment. Ask what information is still needed after a blood test and which clinician will interpret the findings in the context of your overall risk.

Put HRT into the complete treatment discussion

The Menopause Society recognizes a bone benefit from systemic hormone therapy, but the decision also includes the individual benefits and risks of using it. Other medicines are available for osteoporosis. The appropriate choice depends on the diagnosis, fracture risk and wider health history, rather than a general claim about hormone optimization.

If you already use HRT, ask what role it plays in your bone plan and whether anything else is needed. If you use only local vaginal estrogen, do not assume it supplies systemic bone protection. The local versus systemic guide explains the treatment distinction.

Daily habits and falls belong in the plan

NIAMS describes physical activity, appropriate nutrition and fall prevention as parts of osteoporosis management. Discuss suitable weight-bearing and strength activities, especially if you have already fractured a bone or have balance difficulties. The aim is a practical routine that is safe for your situation, not a generic exercise challenge.

Ask whether your diet supplies adequate calcium, vitamin D and protein, and whether supplements are needed. More is not automatically better. Bring existing supplement labels to avoid overlooking duplicate ingredients. A clinician can also help identify changes at home or medication-related issues that affect falls.

Revisit bone health when treatment changes

If you are thinking about ending systemic HRT, ask whether the bone-health plan needs to change at the same time. Our stopping HRT guide helps separate that medical review from an online subscription cancellation. Do not assume that a previous prescription settles future fracture risk indefinitely.

Leave the visit knowing whether a scan or risk assessment is needed, who orders it and when results will be reviewed. If osteoporosis treatment is prescribed, ask how its response and ongoing need will be assessed. Those concrete next steps are more useful than a broad assurance that a hormone plan supports healthy aging.